GLP-1s Linked to No Increased Thyroid Cancer Risk, Study Reveals
New Study Reassures: GLP-1 Receptor Agonists show No Meaningful Short-Term Risk of Thyroid Cancer A groundbreaking study has provided much-needed clarity on the potential link between GLP-1 receptor agonists (GLP-1 RAs) and thyroid cancer, offering reassurance to millions of patients and healthcare providers. The research, led by Anton Pottegard, PhD, of the University of Southern … Read more